EUR 1.02
(5.7%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | N/A |
2022 | - USD | 0.0% |
2021 | - USD | N/A |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BioNTech SE | 3.81 Billion EUR | 100.0% |
CureVac N.V. | 53.75 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 684.6 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 684.6 Million EUR | 100.0% |
BRAIN Biotech AG | 55.33 Million EUR | 100.0% |
Formycon AG | 77.69 Million EUR | 100.0% |
Heidelberg Pharma AG | 9.85 Million EUR | 100.0% |
Medigene AG | 6.03 Million EUR | 100.0% |